DexCom, the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription via the company’s website.
Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate glucose sensing technology. It is specifically designed to provide the 125 million Americans 6 with Type 2 diabetes not using insulin and those with prediabetes with powerful, personalized glucose insights sent directly to a smartphone, revealing how food, exercise and sleep can affect glucose – all without painful fingersticks, Dexcom said in a press release.
“Dexcom has been at the forefront of glucose biosensing for 25 years. With the launch of Stelo, we’re defining a brand-new category and once again setting the gold standard for people to easily take control of their health,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “Now, millions more have access to 24/7, easy-to-understand glucose insights that can inform their daily lifestyle choices and support behavior modification.”
The benefits of glucose biosensing have been shown when used alone, or alongside other diabetes and weight management medications. 7 Studies show the use of Dexcom glucose biosensing by people with Type 2 diabetes is associated with clinically meaningful improvement in time in range, A1c and quality of life.
Related Abbott Receives FDA Clearance for Two CGMs
“Dexcom glucose biosensors are an essential and proven tool for diabetes management – driving strong clinical outcomes regardless of medication use 9 and even potentially slowing the progression of diabetes,” said Thomas Grace, MD, head of clinical advocacy and outcomes at Dexcom. “In a world where GLP-1 use is becoming increasingly more common, glucose biosensors like Stelo can help make those medications more effective.”
Key features of Stelo
• No fingersticks, ever: The only over-the-counter glucose biosensor designed for people with diabetes that doesn’t require any fingersticks.
• Up to 15-day wear time and waterproof: The longest biosensor wear time on the market ‡ with the highest waterproof rating.
• A personalized, easy-to-use app: Provides daily, weekly and session summary insights that can help form healthier habits.
• Spike and pattern detection: The only over-the-counter glucose biosensor for people with diabetes featuring spike detection, designed to identify meaningful glucose variability as it happens so users can make informed changes.
• Proven results with Dexcom glucose sensors: Using Dexcom glucose sensors like Stelo helps lower A1c for people with Type 2 diabetes and may help slow the progression of diabetes. Only Dexcom glucose sensors have been associated with significant improvements in glucose and cardiovascular risk reduction measures as early as three months.
Effortless ordering, delivered directly to your door
Stelo improves access to critical health technology for people with Type 2 diabetes not using insulin and those with prediabetes who might not have insurance coverage for prescription glucose biosensors. Stelo is currently available for purchase in the U.S. at Stelo.com and is FSA and HSA eligible.
• Pay-as-you-go: Pay $99 for a single pack of two sensors (total wear time up to 30 days).
• Monthly subscription: Subscribe and save 10%. Pay $89 per month for an ongoing subscription, with two sensors (total wear time up to 30 days) delivered every 30 days.
Stelo is now part of Dexcom’s overall portfolio of glucose biosensors, with a user base of more than 2.5 million people globally. The Dexcom portfolio in the U.S. consists of the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring Systems, and now Stelo, collectively designed to address the needs of people with all types of diabetes and prediabetes.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom works to simplify and improve diabetes management around the world.
